Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Which Index Funds Had Best Yearly Returns Historically
Which Index Funds Had Best Yearly Returns Historically reveals top performers by year, helping you compare success across funds.
25,767 articlesJune Jobs Report Shows Tiny Payroll Gain, 4.2% Unemployment
The June payroll gain came in at 57,000, with the unemployment rate slipping to 4.2%. Revisions to April and May pain...
Alphabet vs Broadcom: Rotate AVGO Into GOOG Chips Ahead
Alphabet is shifting from relying on Broadcom to building its own AI chips, aiming to feed GOOG’s hyperscale cloud wh...
Paychex Chairman Gave Away 9,309 Shares: What It Means
A high-profile insider move raises questions about strategy and sentiment. This article breaks down the Paychex share...
Ripple XRP Price Outlook This Week: XRP Rally Eyes $1.60
XRP starts the week trading around $1.52 as it tests critical levels near $1.60 and $1.40, with volatility mounting a...
Centrus Energy Stock Potential: Buy Now or Overhyped?
As energy demand grows—from data centers to next-gen reactors—centrus energy stock potential captures the imagination...
Anthropic’s Claude Overtakes ChatGPT in App Store Push
In a surprising turn, anthropic’s claude overtakes chatgpt on the App Store as users rally against OpenAI. The move c...
After Beating Expectations Safe: Is PLUG Stock a Buy?
Plug Power recently beat quarterly estimates, but that isn’t a guarantee the stock is safe to buy. This guide breaks ...
Figma's Stock Trading Like AI Buzz: Is Risk Misread?
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...
Post (Post) 2026 Earnings: Q2 Insight and Analysis
As POST releases its Q2 2026 numbers, investors crave clarity on growth, margins, and guidance. This article breaks d...
Amplitech (AMPG) 2026 Earnings Outlook and Strategy
Investors are watching amplitech (ampg) for clues about growth, margins, and 2026 strategy. This article breaks down ...
Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status